Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Margaret Z. Jones"'
Publikováno v:
Animal Genetics. 17:183-190
Plasma levels of beta-mannosidase activity were measured in the phenotypically normal members of a family of goats in which 12 cases of beta-mannosidosis have been reported. Normal or carrier genotypes were assigned on the basis of these results, and
Autor:
Stacey A. Kraemer, Kathryn L. Lovell, Jodi Nichols-Torrez, Margaret Z. Jones, Kawanaa D. Carter, N. Kent Ames, Jeffrey R. Leipprandt, D.J. Sprecher, Darush K. Rahmani
Publikováno v:
Fetal Diagnosis and Therapy. 16:13-17
Objectives: We explored the feasibility and efficacy of in utero hematopoietic stem cell transplantation in the caprine animal model system with the objectives of determining procedures for transplantation and establishing methods for detecting engra
Publikováno v:
Journal of Biological Chemistry. 275:40641-40648
We have investigated the ability of the mitogen-activated protein kinase (MAPK) kinase MKK6 to activate different members of the p38 subfamily of MAPKs and found that some MKK6 mutants can efficiently activate p38alpha but not p38gamma. In contrast,
Autor:
John J. Hopwood, Stacey A. Kraemer, John C. Baker, Kevin T. Cavanagh, Barbara King, Erinn Downs-Kelly, Joseph Alroy, Margaret Z. Jones, Rebecca E. Lucas
Publikováno v:
Journal of Molecular Neuroscience. 15:251-262
Mucopolysaccharidosis type IIID (MPS IIID) is a lysosomal storage disorder resulting from lack of activity of the lysosomal hydrolase N-acetylglucosamine 6-sulfatase (6S) (EC 3.1.6.14). The syndrome is associated with systemic and central nervous sys
Autor:
Karen H. Friderici, Margaret Z. Jones, Juliann E. Horvath, Jeffrey R. Leipprandt, Hong Chen, Xiao Tan Qiao
Publikováno v:
Mammalian Genome. 10:1137-1141
Beta-mannosidase deficiency results in beta-mannosidosis, a severe neurodegenerative lysosomal storage disease identified in cattle, goats, and humans. To more fully understand the molecular pathology of this disease, the mutation associated with bov
Publikováno v:
Veterinary Pathology. 36:157-160
Three Quarter Horses, a stillborn filly (horse No. 1), a female fetus aborted at approximately 6 months of gestation (horse No. 2), and a 1-month-old colt that had been weak at birth (horse No. 3), had myopathy characterized histologically by large s
Autor:
Kent Johnson, Philip J. Boyer, Shyh Shyurng Liour, John J. Hopwood, Robert A. Leedle, Beverly A. L. Levene, Douglas A. Gage, P. Sharp, Margaret Z. Jones, Ralph S. Common, J. A. Render, Rebecca E. Lucas, Kevin T. Cavanagh, Joseph Alroy, Joseph Vorro, Heidi M. Hoard, Charles T. Lowrie
Publikováno v:
Journal of Neuropathology and Experimental Neurology. 57:148-157
Several animal models have been developed for the mucopolysaccharidoses (MPSs), a group of lysosomal storage disorders caused by lysosomal hydrolase deficiencies that disrupt the catabolism of glycosaminoglycans (GAG). Among the MPS, the MPS-III (San
Publikováno v:
Journal of Molecular Neuroscience. 11:223-232
The use of recombinant lysosomal enzymes for enzyme replacement therapy (ERT) is likely to be a necessary component of effective treatment regimens for lysosomal storage diseases (LSDs). The mechanism and rate of uptake into target cells, rate of dis
Autor:
John W. Taylor, Ellsworth C. Alvord, W. Evans, Kevin T. Cavanagh, David A. Thorley-Lawson, Joseph Alroy, Christopher J. Ianelli, Jennifer R. Toone, Derek A. Applegarth, David Sillence, P. Sharp, Ehud Skutelsky, Margaret Z. Jones, Joe C. Rutledge, Albert Arias, Cynthia Mitchell-Herpolsheimer, John J. Hopwood
Publikováno v:
Journal of Neuropathology and Experimental Neurology. 56:1158-1167
Mucopolysaccharidosis IIID (MPS IIID) is one of the rarest of the MPS-III syndromes. To date, the clinical manifestations of 10 patients have been reported, the deficient N-acetylglucosamine 6-sulfatase (G6S) enzyme has been purified, and the G6S gen
Autor:
Kathryn L. Lovell, Jon S. Patterson, N. K. Ames, F. Matsuura, G. Baeverfjord, Margaret Z. Jones
Publikováno v:
Prenatal Diagnosis. 17:551-557
Lysosomal storage diseases associated with early-onset pathological changes may require prenatal therapy to avert the profound effects of the metabolic error on organs, especially the central nervous system. The present investigation determined the e